Page last updated: 2024-09-03

fullerene c60 and Acquired Immune Deficiency Syndrome

fullerene c60 has been researched along with Acquired Immune Deficiency Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Hill, CL; Schinazi, RF; Sijbesma, R; Srdanov, G; Wudl, F1
Mashino, T1

Reviews

1 review(s) available for fullerene c60 and Acquired Immune Deficiency Syndrome

ArticleYear
[Development of Bio-active Fullerene Derivatives Suitable for Drug].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2022, Volume: 142, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Agents; Antioxidants; Antiviral Agents; Drug Discovery; Fullerenes; Hepatitis C; Humans; Solubility; Virus Replication; Water

2022

Other Studies

1 other study(ies) available for fullerene c60 and Acquired Immune Deficiency Syndrome

ArticleYear
Synthesis and virucidal activity of a water-soluble, configurationally stable, derivatized C60 fullerene.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:8

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Carbon; Cells, Cultured; Drug Stability; Fullerenes; HIV-1; Humans; Leukocytes, Mononuclear; Molecular Conformation; Structure-Activity Relationship; Virus Replication

1993